These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 24388506

  • 1. Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
    Bhidayasiri R, Jitkritsadakul O, Boonrod N, Rerknimitr R.
    Clin Neurol Neurosurg; 2014 Jan; 116():1-3. PubMed ID: 24388506
    [No Abstract] [Full Text] [Related]

  • 2. Levodopa-carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: first documented case.
    Zlotnik Y, Giladi N, Hilel A, Shapira Y, Goldstein S, Gurevich T.
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1317-8. PubMed ID: 25262534
    [No Abstract] [Full Text] [Related]

  • 3. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
    Zibetti M, Rizzone M, Merola A, Angrisano S, Rizzi L, Montanaro E, Cicolin A, Lopiano L.
    Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients.
    Slevin JT, Fernandez HH, Zadikoff C, Hall C, Eaton S, Dubow J, Chatamra K, Benesh J.
    J Parkinsons Dis; 2015 May; 5(1):165-74. PubMed ID: 25588353
    [Abstract] [Full Text] [Related]

  • 5. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.
    Zibetti M, Merola A, Artusi CA, Rizzi L, Angrisano S, Reggio D, De Angelis C, Rizzone M, Lopiano L.
    Eur J Neurol; 2014 Feb; 21(2):312-8. PubMed ID: 24313838
    [Abstract] [Full Text] [Related]

  • 6. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.
    Willows T, Dizdar N, Nyholm D, Widner H, Grenholm P, Schmiauke U, Urbom A, Groth K, Larsson J, Permert J, Kjellander S.
    J Parkinsons Dis; 2017 Feb; 7(4):719-728. PubMed ID: 28984615
    [Abstract] [Full Text] [Related]

  • 7. 24 h Levodopa-carbidopa intestinal gel may reduce falls and "unresponsive" freezing of gait in Parkinson's disease.
    Chang FC, Tsui DS, Mahant N, Wolfe N, Kim SD, Ha AD, Drury M, Griffith JM, Fung VS.
    Parkinsonism Relat Disord; 2015 Mar; 21(3):317-20. PubMed ID: 25578290
    [Abstract] [Full Text] [Related]

  • 8. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.
    Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ.
    Mov Disord; 2015 Apr; 30(4):500-9. PubMed ID: 25545465
    [Abstract] [Full Text] [Related]

  • 9. Levodopa/carbidopa intestinal gel therapy for advanced Parkinson Disease: AN early toxic effect for small nerve fibers?
    Devigili G, Rinaldo S, Lettieri C, Eleopra R.
    Muscle Nerve; 2016 Nov; 54(5):970-972. PubMed ID: 27514937
    [Abstract] [Full Text] [Related]

  • 10. The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.
    Lowin J, Sail K, Baj R, Jalundhwala YJ, Marshall TS, Konwea H, Chaudhuri KR.
    J Med Econ; 2017 Nov; 20(11):1207-1215. PubMed ID: 28895769
    [Abstract] [Full Text] [Related]

  • 11. Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
    Pålhagen SE, Sydow O, Johansson A, Nyholm D, Holmberg B, Widner H, Dizdar N, Linder J, Hauge T, Jansson R, Bergmann L, Kjellander S, Marshall TS.
    Parkinsonism Relat Disord; 2016 Aug; 29():17-23. PubMed ID: 27318707
    [Abstract] [Full Text] [Related]

  • 12. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
    Wirdefeldt K, Odin P, Nyholm D.
    CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
    [Abstract] [Full Text] [Related]

  • 13. Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.
    Valldeoriola F, Grandas F, Santos-García D, Regidor I, Catalán MJ, Arbelo JM, Puente V, Mir P, Parra JC.
    Neurodegener Dis Manag; 2016 Aug; 6(4):289-98. PubMed ID: 27440190
    [Abstract] [Full Text] [Related]

  • 14. Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study.
    Moes HR, Groenendal-Laurensse JWMJ, Drent M, Tissingh G, van Laar T.
    J Parkinsons Dis; 2020 Aug; 10(3):935-944. PubMed ID: 32675420
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
    Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ.
    Mov Disord; 2018 Jul; 33(6):928-936. PubMed ID: 29570853
    [Abstract] [Full Text] [Related]

  • 16. [Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety].
    Timofeeva AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014 Jul; 114(11):145-51. PubMed ID: 25629138
    [Abstract] [Full Text] [Related]

  • 17. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
    Juhász A, Aschermann Z, Ács P, Janszky J, Kovács M, Makkos A, Harmat M, Tényi D, Karádi K, Komoly S, Takáts A, Tóth A, Nagy H, Klivényi P, Dibó G, Dézsi L, Zádori D, Annus Á, Vécsei L, Varannai L, Kovács N.
    Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758
    [Abstract] [Full Text] [Related]

  • 18. Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Imai H, Nakamura T, Kondo T, Narabayashi H.
    Adv Neurol; 1993 Apr; 60():622-5. PubMed ID: 8420201
    [No Abstract] [Full Text] [Related]

  • 19. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
    Kovács N, Aschermann Z, Ács P, Bosnyák E, Deli G, Janszky J, Komoly S.
    Ideggyogy Sz; 2014 Jul 30; 67(7-8):245-50. PubMed ID: 25509365
    [Abstract] [Full Text] [Related]

  • 20. Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel.
    Ray Chaudhuri K, Antonini A, Robieson WZ, Sanchez-Soliño O, Bergmann L, Poewe W, GLORIA study co-investigators.
    Eur J Neurol; 2019 Apr 30; 26(4):581-e43. PubMed ID: 30353942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.